Skip to main content

Table 2A Adjusted multivariate Cox regression model for exercise stress testing

From: Prognostic value of exercise capacity in incident diabetes: a country with high prevalence of diabetes

 

Model (1)

Model (2)

Model (3)

Model (4 A)

Model (4B)

 

HR (95% CI)

p

HR (95% CI)

p

HR (95% CI)

p

HR (95% CI)

p

HR (95% CI)

p

Age (years)

1.032 (1.03–1.04)

< 0.001

1.028 (1.02–1.03)

< 0.001

1.028 (1.02–1.03)

< 0.001

1.022 (1.02–1.03)

< 0.001

1.02 (1.02–1.02)

< 0.001

Gender (Female vs. Male)

1.131 (1.03–1.24)

0.009

1.176 (1.07–1.29)

0.001

1.138 (1.04–1.25)

0.007

0.892 (0.81–0.99)

0.027

0.87 (0.79–0.96)

0.007

Resting heart rate (bpm)

1.002 (1.00–1.00)

0.109

1.003 (1.00-1.01)

0.011

1.004 (1.00-1.01)

0.003

1.002 (1.00-1.01)

0.109

1.001 (1.00–1.00)

0.452

Cardiovascular risk factors

          

 Hypertension

  

1.189 (1.08–1.31)

< 0.001

1.138 (1.03–1.26)

0.015

1.06 (0.95–1.18)

0.284

1.059 (0.95–1.18)

0.293

 Hyperlipidemia

  

1.196 (1.08–1.32)

< 0.001

1.502 (1.36–1.66)

< 0.001

1.537 (1.39–1.70)

< 0.001

1.539 (1.39–1.71)

< 0.001

 Smoking

  

1.202 (0.94–1.54)

0.150

1.241 (0.97–1.59)

0.090

1.19 (0.93–1.52)

0.167

1.178 (0.92–1.51)

0.193

 Lung disease

  

1.06 (0.77–1.46)

0.720

0.961 (0.69–1.34)

0.814

0.94 (0.67–1.31)

0.716

0.908 (0.65–1.27)

0.572

 Known CAD

  

1.154 (0.98–1.36)

0.092

1.149 (0.97–1.37)

0.117

1.18 (0.99–1.40)

0.060

1.189 (1.00-1.41)

0.049

 Known CHF

  

0.588 (0.36–0.97)

0.039

0.483 (0.29–0.81)

0.005

0.431 (0.26–0.72)

0.001

0.429 (0.26–0.71)

0.001

Medications

          

 Statins

    

0.332 (0.28–0.40)

< 0.001

0.338 (0.28–0.41)

< 0.001

0.338 (0.28–0.41)

< 0.001

 PPI

    

1.632 (1.32–2.01)

< 0.001

1.563 (1.27–1.93)

< 0.001

1.568 (1.27–1.94)

< 0.001

 CCB

    

0.994 (0.81–1.21)

0.955

1.005 (0.82–1.23)

0.964

0.999 (0.82–1.22)

0.993

 BB

    

1.697 (1.38–2.09)

< 0.001

1.615 (1.31–1.99)

< 0.001

1.588 (1.29–1.96)

< 0.001

 ACE/ARB

    

0.996 (0.86–1.15)

0.951

0.979 (0.85–1.13)

0.771

0.988 (0.86–1.14)

0.866

 Diuretic

    

1.187 (0.95–1.48)

0.124

1.182 (0.95–1.47)

0.138

1.164 (0.93–1.45)

0.178

METs (Categories)

          

 METs 6–9

      

0.871 (0.75–1.01)

0.073

  

 METs 10–11

      

0.619 (0.52–0.73)

< 0.001

  

 METs ≥ 12

      

0.482 (0.39–0.59)

< 0.001

  

METs (Continuous)

        

0.90 (0.88–0.92)

< 0.001

Chronotropic incompetence

      

1.119 (1.01–1.24)

0.030

1.056 (0.95–1.17)

0.303

Duke Risk Score

          

 High Risk

      

1.293 (1.00-1.67)

0.048

1.257 (0.97–1.62)

0.078

 Moderate Risk

      

1.26 (1.14–1.39)

< 0.001

1.21 (1.10–1.33)

< 0.001

  1.  h: Hazard ratio, CI: confidence interval, CAD: Coronary artery disease, CHF: Congestive heart failure, PPI: Proton pump inhibitors, CCB: Calcium channel blocker, BB: beta-blockers, ACE/ARB: Angiotensin-converting enzyme/Angiotensin receptor blockers, METs: Metabolic equivalent of tasks,